You just read:

Animas Makes Progress in Development of a First-Generation Closed-Loop Insulin Delivery System With Study Participants Maintaining Safe Glucose Levels for Over 90 Percent of the Overnight Period

News provided by

Animas Corporation

Jun 24, 2013, 09:00 ET